Enhancement by Recombinant Human Bone Morphogenetic Protein-2 of Bone Formation by Means of Porous Hydroxyapatite in Mandibular Bone Defects

Abstract

Hydroxyapatite is osteoconductive and can maintain an original biocompatible form. It is useful, in the reconstruction of bone defects, to enhance the osteoconduction of hydroxyapatite with an osteogenic protein. The aim of this study was to evaluate the bone formation in surgically created defects of rabbit mandibles by a combination of recombinant human bone morphogenetic protein-2 (rhBMP-2), with porous hydroxyapatite and atelopeptide type I collagen used as the carrier for rhBMP-2. A 10-μg rhBMP-2-implanted group (n = 15) and a control group (n = 15), in which only atelopeptide type I collagen and porous hydroxyapatite were implanted, were histologically examined 3, 7, and 21 days after implantation. The alkaline phosphatase activity was also quantitatively analyzed. No new bone formation was observed in either the tested or the control group after 3 days. At 7 days, immature bone tissue was observed in some pores of the rhBMP-2implanted group, while in the control group, immature mesenchymal cells were observed. At 21 days, trabecular bone lined some pore walls. In the central portion, the bone marrow, including angioid tissue, was observed. New trabecular bone formation was observed on portions of the external surface of the hydroxyapatite disk. On the other hand, the control group showed infiltration of immature mesenchymal cells into some pores. Marginal bone formation was found in the pores close to the surface of the disk which opposed mandibular bone. The control group showed a slow, small increase in alkaline phosphatase activity in this study, while the experimental group showed a marked increase at 21 days. This increase was significantly higher in the tested group than in the control group at both 7 and 21 days. The findings indicate that rhBMP-2 accelerated bone formation by osteoconduction from porous hydroxyapatite. The combination of rhBMP-2, atelopeptide type I collagen, and porous hydroxyapatite is suggested to be advantageous for clinical application in reconstructing mandibular bone defects.

Keywords

bone morphogenetic protein hydroxyapatite osteoinduction osteoconduction mandible

Get full access to this article

View all access options for this article.

References

Bessho K. (1990). Purification and characterization of bone morphogenetic protein. Mie Med J 40:61-71.

Bessho K. , Tagawa T. , Murata M. (1989). Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem Biophys Res Commun 165:595-601.

Byrd HS , Hobar PC , Shewmake K. (1993). Augmentation of the orofacial skeleton with porous hydroxyapatite granules. Plast Reconstr Surg 91:15-22.

Fujimura K. , Bessho K. , Kusumoto K. , Ogawa Y. , Iizuka T. (1995). Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 208:316-322.

Holmes RE , Bucholz RW , Mooney V. (1987). Porous hydroxyapatite as a bone-graft substitute in diaphyseal defects: a histometric study. J Orthop Res 5:114-121.

Jarcho M. (1981). Calcium phosphate ceramics as hard tissue prosthetics . Clin Orthop 157:259-278.

Kawamura M. , Iwata H. , Sato K. , Miura T. (1987). Chondroosteogenetic response to crude bone matrix proteins bound to hydroxyapatite. Clin Orthop 217:281-292.

Klawitter JJ , Hulbert SF (1971). Application of porous ceramics for attachment of load bearing internal orthopedic applications. J Biomed Mater Res 2:161-229.

Kusumoto K. , Bessho K. , Fujimura K. , Konishi Y. , Ogawa Y. , Iizuka T. (1995). Comparative study of bone marrow induced by purified BMP and recombinant human BMP-2. Biochem Biophys Res Commun 215:205-211.

10.

Kusumoto K. , Bessho K. , Fujimura K. , Konishi Y. , Ogawa Y. , Iizuka T. (1996). Self-regenerating bone implant: ectopic osteoinduction following intramuscular implantation of a combination of rhBMP-2, atelopeptide type 1 collagen and porous hydroxyapatite. J Cranio Maxillofac Surg 24:360-365.

11.

Levine JP , Bradley J. , Turk AE , Ricci JL , Benedict JJ , Steiner G. , et al. (1997). Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit. Ann Plast Surg 39:158-168.

12.

Miller TA , Ishida K. , Kobayashi M. , Wollman JS , Turk AE , Holmes RE (1991). The induction of bone by an osteogenic protein and the conduction of bone by porous hydroxyapatite: a laboratory study in the rabbit. Plast Reconstr Surg 87:87-95.

13.

Ono I. , Ohura T. , Murata M. , Yamaguchi H. , Ohnuma Y. , Kuboki Y. (1992). A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast Reconstr Surg 90:870-879.

14.

Ono I. , Gunji H. , Suda K. , Kaneko F. , Murata M. , Saito T. , et al. (1995). Bone induction of hydroxyapatite combined with bone morphogenetic protein and covered with periosteum. Plast Reconstr Surg 95:1265-1272.

15.

Rosen HM (1989). Porous, block hydroxyapatite as an interpositional bone graft substitute in orthognathic surgery. Plast Reconstr Surg 83:985-990.

16.

Reddi AH , Cunningham NS (1993). Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8:499-502.

17.

Salyer KE , Hall CD ( 1989). Porous hydroxyapatite as an onlay bone-graft substitute for maxillofacial surgery. Plast Reconstr Surg 84:236-244.

18.

Takaoka K. , Nakamura H. , Yoshikawa H. , Masuhara K. , Tsuda T. , Ono K. (1988). Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 234:250-254.

19.

Takaoka K. , Koezuka M. , Nakazawa H. (1991). Telopeptidedepleted bovine skin collagen as a carrier for bone morphogenetic protein. J Orthop Res 9:902-907.

20.

Taylor SM , Jones PA (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.

21.

Tsuruga E. , Takita H. , Itoh H. , Wakisaka Y. , Kuboki Y. (1997). Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem Tokyo 121:317-324.

22.

Urist MR (1965). Bone: formation by autoinduction. Science 150:893-899.

23.

Urist MR , Huo YK , Brownell AG , Hohl WM , Buyske J. , Lietze A. , et al. (1984). Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA 81:371-375.

24.

Wozney JM , Rosen V. , Celeste AJ , Mitsock LM , Whitters MJ , Kriz RW , et al. (1988). Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534.

25.

Yoshida K. , Bessho K. , Fujimura K. , Kusumoto K. , Ogawa Y. , Tani Y. , et al. (1998). Osteoinducing ability by recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites-an experimental study. J Cranio Maxillofac Surg 26:112-115.